TCT 2021: Late-breaking Science Video Collection
Published: 09 November 2021
-
Views:
2350 -
Likes:
7
-
Views:
2350 -
Likes:
7
-
Up Next
-
22m 33sPart 1 | Session 2 View from the Thoraxcenter: TCT 21 Late-breaking Science Wrap Up
-
10m 32s
-
4m 40sPart 2 | Session 2 iFR-SWEDEHEART: No Difference in Outcome at 5-yrs of iFR vs FFR
-
8m 19s
-
7m 32sPart 2 | Session 4 CHOICE-CLOSURE: Plug-based Vs Suture-based Large-bore Vascular Closure
-
7m 27sPart 2 | Session 5 TRISCEND II: 6Mo Outcomes Show TR Reduction in Majority of Patients
-
8m 8sPart 2 | Session 6 SCB Shows Similar Angiographic Outcomes to Paclitaxel DCB
-
3m 37sPart 2 | Session 7 Intrepid TMVR: Results Show Improved NYHA Class at 30 Days
-
6m 43s
-
4m 44s
-
4m 28sPart 2 | Session 10 BIO-RESORT: 5Y Outcomes
-
10m 19sPart 2 | Session 11 OPTIMUM Registry: PCI in Patients at Prohibitive Risk for CABG
Overview
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provide a concise and insightful preview of the late-breaking science presented at TCT 2021.
Short, accessible Expert Interviews will be available conducted with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Part 1
View from the Thoraxcenter: Preview of the Late-Breaking Trials
Part 2
Expert Interviews
Faculty Biographies
Nicolas M Van Mieghem
Medical Director
Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
His current research focuses on cerebral embolic protection during TAVI and the search for improved…
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.